SHALBY LIMITED Intrinsic Value

SHALBY · Healthcare · Current price ₹153.66

Full stock page
DocStoX fair value
₹132
low confidence
Current price
₹154
Upside to fair value
-13.8%
Verdict
Expensive
Quality score
2.8 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with SHALBY LIMITED's latest numbers.

Is SHALBY LIMITED undervalued?

DocStoX estimates the fair value of SHALBY LIMITED at ₹132 per share, versus the current market price of ₹154. That puts the stock about -13.8% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹84), Relative P/E (₹224), Graham floor (₹85), Analyst target (₹173). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹84 (bear) to ₹132 (base) to ₹224 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹154 versus an intrinsic value of ₹132, SHALBY LIMITED currently offers -13.8% of negative margin (i.e. a premium).

More on SHALBY LIMITED

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.